[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4965 followers Created: 2025-07-20 14:22:42 UTC 🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists All six RCTs used treatment durations ≥40 weeks. GLP-1 RAs showed sustained weight loss and metabolic improvements across diabetic and non-diabetic cohorts. #GLP1 #RCT $NVO $LLY XX engagements  **Related Topics** [$lly](/topic/$lly) [ras](/topic/ras) [longterm](/topic/longterm) [weight loss](/topic/weight-loss) [$nvo](/topic/$nvo) [stocks healthcare](/topic/stocks-healthcare) [eli lilly](/topic/eli-lilly) [Post Link](https://x.com/AponiaAnalytics/status/1946938823163728174)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
aponia_analytics @AponiaAnalytics on x 4965 followers
Created: 2025-07-20 14:22:42 UTC
🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists
All six RCTs used treatment durations ≥40 weeks. GLP-1 RAs showed sustained weight loss and metabolic improvements across diabetic and non-diabetic cohorts. #GLP1 #RCT $NVO $LLY
XX engagements
Related Topics $lly ras longterm weight loss $nvo stocks healthcare eli lilly
/post/tweet::1946938823163728174